{
  "CSP_FORM": "CSP Application Form",
  "APPLICANTNAME": "Applicant Name",
  "COMPANY_NOABBREV": "Company Name (Full legal Name - no abbreviations)",
  "DATE_APPL_REC": "Date Application Received",
  "CSP_COMPANY_CODE": "CSP Company Code",
  "CSP_APPLICATION_CODE": "CSP Application Number",
  "NOTES": "Notes",
  "HCONLY": "Health Canada Use Only",
  "BILLING_DIFFERENT": "Select to enter a billing address that is different from the Applicantâ€™s Contact Information",
  "ADVANCE_FEE_PAYMENT": "The fee is being paid  or the fee has been prepaid in the amount of (please enter the fee amount) ",
  "PAYMENT_METHOD": "Method of Advance Payment",
  "FINANCIAL": "Payment through a Canadian Financial Institution",
  "CHEQUE": "Cheque / Bank Draft / Money Order",
  "CREDIT_CARD": "MasterCard / Visa / American Express (AMEX) / Visa Debit / JCB International",
  "CREDIT": "Payment Using Existing Credit",
  "WIRE": "Wire",
  "HUMAN": "Human",
  "VETERINARY": "Veterinary",
  "DRUGUSE": "Drug use",
  "DATE_FILED": "Patent Filing Date",
  "DATE_GRANTED": "Patent Date Granted",
  "DATE_EXPIRY": "Patent Expiration Date",
  "NDS_NUMBER": "NDS Number",
  "MED_INGRED": "Medicinal ingredient(s) (as provided on the NOC for the NDS provided in Section 3)",
  "APPLICANTAPPLY": "Attestation as to Applicant",
  "STATEMENTS_TIMELY": "Attestation as to Timely Submission",
  "TIMELYDATE": "Date of first marketing approval application",
  "TIMELYCOUNTRY": "Country of first marketing approval application",
  "DATE_SIGNED": "Date",
  "CSP_TITLE": "Certificate of Supplementary Protection (CSP) Information",
  "NDS_TITLE": "New Drug Submission (NDS) Information",
  "DRUGUSE_TITLE": "Drug Use",
  "TIMEAPP_TITLE": "Timing of Application",
  "NOC_120": "on the basis of a patent granted on or before the day on which the Notice of Compliance (NOC) for the above noted NDS is issued (before the end of the 120-day period that begins on the day on which the NOC is issued), or",
  "GRANT_120": "on the basis of a patent granted after the day on which the Notice of Compliance (NOC) for the above noted NDS is issued (before the end of the 120-day period that begins on the day on which the patent is granted)",
  "APPLICANT_OWNER": "The Applicant is the patentee and is recorded as an owner of the above noted Canadian Patent at the Canadian Intellectual Property Office.",
  "APPLICANT_BEHALF": "The Applicant is a manufacturer who is authorized by the person recorded in the Canadian Intellectual Property Office as the owner of the above noted Canadian Patent to file this application on their behalf and the above noted NDS was issued to the Applicant.",
  "PATENT_TITLE": "Patent Information",
  "APPLICANT_APPLY": "Applicant is applying (select one only)",
  "FEE_TITLE": "Fee Payment",
  "LOAD_CSP_FILE": "Load a Saved Certificate of Supplementary Protection Application File",
  "CERT_TITLE": "Certification",
  "BILLING_TITLE": "Billing Address",
  "APPL_TITLE": "Applicant Information",
  "PATENTNUM": "Canadian Patent Number",
  "MSG_LENGTH_7NUM": "Please enter 7 digits.",
  "OTHER_EU_COUNTRY": " Other European Union Country Details",
  "CERT_FS": "Name of Authorized Official",
  "CONTACT_TITLE": "Applicant Contact Information (where all communications regarding the CSP will be sent)",
  "ACK_FEE_SUBMIT": "The Advance Payment Details form is being submitted separately by fax or mail",
  "MEDINGRED_TITLE": "Medicinal Ingredient(s)",
  "STATEMENT_TITLE": "Attestations",
  "NOAPPLICATION": "When the application for the authorization for sale referred to in paragraph 106(1)(c) of the <i>Patent&nbsp;Act</i> (above noted NDS) was filed with the Minister of Health, no application for a marketing approval, equivalent to an authorization for sale, with respect to the medicinal ingredient or combination of medicinal ingredients, as the case may be, set out in this CSP application had been submitted in the European Union or any country that is a member of the European Union, the United States of America, Australia, Switzerland or Japan.",
  "APPLICATION":"If one or more applications for a marketing approval, equivalent to an authorization for sale, with respect to the medicinal ingredient or combination of medicinal ingredients, as the case may be, set out in this CSP application had been submitted in one or more of the European Union or any country that is a member of the European Union, the United States of America, Australia, Switzerland or Japan, the application for the authorization for sale referred to in paragraph 106(1)(c) of the <i>Patent&nbsp;Act</i> (above noted NDS) was filed with the Minister of Health before the end of the 18 month period that begins on the date of submission of the first of those marketing approval applications.  Details of the first of those marketing approval applications are as follows:",
  "FEE_PREAMBLE":"This form <b>should not</b> include payment information (e.g. credit card number) other than as specifically requested below, as the information included within an electronic submission cannot be deleted and will remain as part of the CSP application on record. As such, please separately <b><u>mail</u></b> or <b><u>fax</u></b> the ",
  "FEE_URL":"http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/prodpharma/applic-demande/form/adv_pa_av-eng.pdf",
  "FEE_URLTITLE":"Advance Payment Details for Drug Submissions and Master Files for Human and Disinfectant Drugs, and Certificate of Supplementary Protection Applications Form",
  "HELP_CSPFILE_LOAD":"Expand File load Instructions",
  "CSPFILE_LOAD":"File load Instructions",
  "VERSION_INSTRUCT":"Expand Version Number Instructions",
  "HELP_PATENT":"Expand Patent Instructions",
  "HELP_FEE":"Expand Fee Payment Instructions",
  "HELP_CERT":"Expand Certification Instructions",
  "HELP_ATTEST":"Expand Attestation Instructions",
  "HELP_DRUGUSE":"Expand Drug Use Instructions",
  "HELP_MI":"Expand Medicinal Ingredient Instructions",
  "HELP_NDS":"Expand New Drug Submission Instructions",
  "HELP_MARKETDATE":"Expand Market Date Instructions",
  "APPLICANT_INSTRUCT":"Expand Applicant Information Instructions",
  "BILLING_INSTRUCT":"Expand Billing Address Instructions",
  "VERSION_INSTRUCT_CLOSE":"Version Number Instructions",
  "PATENT_INSTRUCT":"Patent Instructions",
  "FEE_INSTRUCT":"Fee Payment Instructions",
  "CERT_INSTRUCT":"Certification Instructions",
  "ATTEST_INSTRUCT":"Attestation Instructions",
  "DRUGUSE_INSTRUCT":"Drug Use Instructions",
  "MI_INSTRUCT":"Medicinal Ingredient Instructions",
  "NDS_INSTRUCT":"New Drug Submission Instructions",
  "MARKETDATE_INSTRUCT":"Market Date Instructions",
  "APPLICANT_CLOSE":"Applicant Information Instructions",
  "BILLING_CLOSE":"Billing Address Instructions",
  "ADVANCE_DETAILS":"(Advance Payment Details form)."

}

